Olivier Van Obberghen is partner at Quinz, an innovative law firm that focuses on advising and assisting (bio-) pharmaceutical, biotech and medical devices companies on transactional, regulatory and intellectual property matters throughout the different stages of the life cycle of drug products and medical devices. Olivier’s expertise mainly focuses on transactional and regulatory questions relating to R&D, clinical development and supply chain.
In the clinical development stage, Olivier negotiates various types of clinical trial agreements with the different actors involved in a clinical trial (sponsors, CRO’s, investigators/hospitals, central labs, freight services providers, data analysts), and assists on legal issues faced when drafting clinical trial protocols and informed consent forms. He also advises on regulatory and other compliance issues (such as GCP, clinical trial applications, payment of fair value, insurance, data privacy).
Olivier was seconded for more than 2 years to the legal department of UCB, and studied law at the Catholic University of Leuven (KU Leuven) and the University of Chicago Law School. He is licensed to practice at the Brussels Bar.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.